Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LOAd-703 by Lokon Pharma for Epithelial Ovarian Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData,...
LOAd-703 by Lokon Pharma for Peritoneal Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase...
LOAd-703 by Lokon Pharma for Fallopian Tube Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Fallopian Tube Cancer. According to GlobalData,...
LOAd-703 by Lokon Pharma for Metastatic Melanoma: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...
LOAd-703 by Lokon Pharma for Metastatic Biliary Tract Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Metastatic Biliary Tract Cancer. According to...
LOAd-703 by Lokon Pharma for Metastatic Colorectal Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
LOAd-703 by Lokon Pharma for Metastatic Pancreatic Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData,...